Showing results (121-130 of 243) with videos related to

Sort By:
Pageof 25
Molecular Cancer Therapeutics|July 2, 2009
Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptorsXiaoqin Yuan, Xinjian Lin, Gerald Manorek, et al.
Molecular Imaging and Biology|August 6, 2010
Biodistribution, pharmacokinetics, and nuclear imaging studies of 111In-labeled rGel/BLyS fusion toxin in SCID mice bearing B cell lymphomaXiaoxia Wen, Mi-Ae Lyu, Rui Zhang, et al.
Cancer Research|June 1, 1985
Modification of human leukocyte interferon pharmacology with a monoclonal antibodyM G Rosenblum, B W Unger, J U Gutterman, et al.
Annals of Internal Medicine|May 16, 2022
Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018Hannah G Rosenblum, Rayleen M Lewis, Julia W Gargano, et al.
Pediatric Research|October 1, 1979
Altered polyamine metabolism in cystic fibrosisD H Russell, M G Rosenblum, R C Beckerman, et al.
Gynecologic Oncology|March 22, 2003
Primary small cell carcinoma of the vaginaJoseph M Kaminski, Penny R Anderson, Aaron C Han, et al.
MMWR. Morbidity and Mortality Weekly Report|March 25, 2021
Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018Hannah G Rosenblum, Rayleen M Lewis, Julia W Gargano, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 1994
Clinical pharmacology and tissue disposition studies of 131I-labeled anticolorectal carcinoma human monoclonal antibody LiCO 16.88M G Rosenblum, B Levin, M Roh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activityL C Pagliaro, B Liu, R Munker, et al.
Biochemical Pharmacology|October 2, 2012
Pharmacodynamics, tissue distribution, toxicity studies and antitumor efficacy of the vascular targeting fusion toxin VEGF121/rGelKhalid A Mohamedali, Gang Niu, Troy A Luster, et al.
Pageof 25